Skip to Content

Pfizer PBC 125 (Ibrance 125 mg)

Generic Name: palbociclib

Pill imprint Pfizer PBC 125 has been identified as Ibrance 125 mg.

Ibrance is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class multikinase inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ibrance 125 mg Pfizer PBC 125
Discount Card Promo
Ibrance
Generic Name:
palbociclib
Imprint:
Pfizer PBC 125
Strength:
125 mg
Color:
Tan
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
CSA Schedule:
Not a controlled drug
Manufacturer:
Pfizer Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide